SEC Form 4 · accession 0001182489-15-000692
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rajiv A Patel
Director · 10% Owner · Other
Period of report
Sep 3, 2015
Accepted (ET)
Sep 8, 2015 · 3:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Share UnitsF1,F2 | $0.125 | Sep 3, 2015 | A | 3,600 | A | Jul 1, 2016 | Jul 1, 2020 | Ordinary Shares | 3,600 | 8,600 | D |
Explanation of responses
- F1Each Restricted Share Unit ("RSU") is convertible into one ordinary share of the Issuer upon vesting, subject to payment by the holder to the Issuer of the nominal value per share ($0.125) within 30 days of vesting.
- F2On September 3, 2015, the Issuer awarded 3,600 RSUs to Rajiv A. Patel, pursuant to the Issuer's 2015 Equity Incentive Plan. Such 3,600 RSUs will vest and become convertible on July 1, 2016.